Trial Progress
BASIL-2 began recruitment in July 2014 and closed recruitment on 30 November 2020. A total of 345 patients were recruited from 41 sites in the UK, Denmark and Sweden.
Participants were followed up for a minimum of 24 months, with maximum follow up of 84 months. Follow up was completed on 31 October 2022.
The results were published in The Lancet on 25 April 2023, and simultaneously presented at the Charing Cross International Symposium in London. Watch Professor Andrew Bradbury reveal the BASIL-2 results at the Symposium.
Thank you to all BASIL-2 participants and study sites for your hard work and commitment over the last eight years.